Th17 cells and HIV infection

被引:40
|
作者
ElHed, Aimee [1 ]
Unutmaz, Derya [1 ,2 ]
机构
[1] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
关键词
HIV; immune activation; simian immunodeficiency virus; Th17; HYPER-IGE SYNDROME; EFFECTOR T-CELLS; ROR-GAMMA-T; AUTOIMMUNE INFLAMMATION; HOST-DEFENSE; HELPER-CELLS; INTERLEUKIN-17; DIFFERENTIATION; CYTOKINE; IL-23;
D O I
10.1097/COH.0b013e32833647a8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review This review summarizes the recent literature about the potential perturbation and role of Th17 cells in HIV pathogenesis. We discuss the recent findings on Th17 deficiency in HIV/simian immunodeficiency virus (SIV) infection and how this deficiency may impact the mucosal host defenses, potentially contributing to chronic immune activation. Recent findings Th17 cells have been implicated in host defense against a variety of pathogens and are involved in the pathogenesis of autoimmune diseases. Recently, Th17 cells were shown to be perturbed during HIV infection in humans and SIV infection in nonhuman primates. Th17 cells were found to be infected in vitro by HIV and SIV and are significantly depleted in the gastrointestinal tract of HIV-infected individuals. In monkeys, Th17 cells are only depleted in the pathogenic SIV infection of rhesus macaques, which correlates with the progression to AIDS in these primates, whereas they remain intact in the nonpathogenic SIV infection of African green monkeys or sooty mangabeys. Summary Th17 cells appear to be perturbed during HIV and SIV infection. This finding could have important implications in understanding the disruption of mucosal defenses in the gastrointestinal tract and potentially in predicting opportunistic infections during the course of HIV disease.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [41] Th17 cells in pathogenic simian immunodeficiency virus infection of macaques
    Cecchinato, Valentina
    Franchini, Genoveffa
    CURRENT OPINION IN HIV AND AIDS, 2010, 5 (02) : 141 - 145
  • [42] Abundant Highly Activated Th17 Cells in the Lower Reproductive Tract of Adolescent Girls at Risk for HIV Infection
    Konstantinus, Iyaloo
    Balle, Christina
    Jaumdally, Shameem
    Tanko, Ramla
    Gill, Katherine
    Bekker, Linda-Gail
    Jaspan, Heather
    Passmore, Jo-Ann
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 303 - 303
  • [43] Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tract
    Rodriguez-Garcia, M.
    Barr, F. D.
    Crist, S. G.
    Fahey, J. V.
    Wira, C. R.
    MUCOSAL IMMUNOLOGY, 2014, 7 (06) : 1375 - 1385
  • [44] Th17 cells and regulatory T cells in elite control over HIV and SIV
    Hartigan-O'Connor, Dennis J.
    Hirao, Lauren A.
    McCune, Joseph M.
    Dandekar, Satya
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (03) : 221 - 227
  • [45] Th17, gut, and HIV: therapeutic implications
    Hunt, Peter W.
    CURRENT OPINION IN HIV AND AIDS, 2010, 5 (02) : 189 - 193
  • [46] T CELLS Plastic TH17 cells
    Leavy, Olive
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (03) : 160 - 160
  • [47] The PPARG antagonism disconnects the HIV replication and effector functions in Th17 cells
    Zhang, Yuwei
    Chen, Huicheng
    Planas, Delphine
    Bernier, Annie
    Gosselin, Annie
    Routy, Jean-Pierre
    Ancuta, Petronela
    RETROVIROLOGY, 2016, 13
  • [48] Using the PPARg antagonism to block/lock HIV reactivation in Th17 cells
    Zhang, Y.
    Planas, D.
    Chen, H.
    Gosselin, A.
    Routy, J. -P.
    Ancuta, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 30 - 31
  • [49] Targeting Th17 cells in HIV-1 remission/cure interventions
    Fert, Augustine
    Marchand, Laurence Raymond
    Salinas, Tomas Raul Wiche
    Ancuta, Petronela
    TRENDS IN IMMUNOLOGY, 2022, 43 (07) : 580 - 594
  • [50] Mitochondria controls TH17 cells
    Stephanie Houston
    Nature Immunology, 2022, 23 : 1400 - 1400